Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biopharma Middle East (BME) is a specialized pharmaceutical company focused on providing commercialization and distribution services for innovative medicines across the Middle East and North Africa (MENA) region. The company acts as a strategic partner for international biotech and pharmaceutical firms, helping them navigate complex regulatory environments and market access challenges to deliver life-saving treatments for rare diseases, oncology, and hematology. BME manages the entire value chain from regulatory registration and medical affairs to marketing and supply chain logistics. By bridging the gap between global innovators and regional patients, the company ensures that advanced therapies for unmet medical needs are accessible in local markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biopharma-Middle East.